Shane Garner
Impact in
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 7
- Pharmaceutical Economics and Policy 5
-
- Antibiotic Use and Resistance 2
- Co-authors
- Harry Ischiropoulos (1 shared paper)Michael Francis Beers (1 shared paper)Stephen R. Thom (1 shared paper)S. Tsuyoshi Ohnishi (1 shared paper)D. L. Fisher (1 shared paper)Jelle Tichelaar (1 shared paper)Nemesha Desai (1 shared paper)Anthony David Ormerod (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (5 papers)Value in Health (2 papers)European Journal of Clinical Pharmacology (1 paper)Journal of Clinical Investigation (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Shane Garner
15 papers receiving 707 citations
Peers
Comparison fields: 5 of 123
- Economics and Econometrics 265
- Applied Microbiology and Biotechnology 15
- Dermatology 57
- Statistics and Probability 53
- Physiology 145
Countries citing papers authored by Shane Garner
This map shows the geographic impact of Shane Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane Garner more than expected).
Fields of papers citing papers by Shane Garner
This network shows the impact of papers produced by Shane Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane Garner. The network helps show where Shane Garner may publish in the future.
Co-authors
The 25 scholars most cited alongside Shane Garner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 212 | |
| 2 | 2015 | 162 | |
| 3 | 1996 | 158 | |
| 4 | 2011 | 60 | |
| 5 | 2016 | 58 | |
| 6 | 2016 | 49 | |
| 7 | 2020 | 25 | |
| 8 | 2016 | 11 | |
| 9 | 2016 | 11 | |
| 10 | 2024 | 4 | |
| 11 | 2016 | 2 | |
| 12 | 2011 | 2 | |
| 13 | 2015 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2024 | 1 |
About Shane Garner
Shane Garner is a scholar working on Economics and Econometrics, Applied Microbiology and Biotechnology, Pediatrics, Perinatology and Child Health, Statistics and Probability and Dermatology, having authored 15 papers that have together received 757 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (5 papers), Statistical Methods in Clinical Trials (2 papers), Additive Manufacturing Materials and Processes (2 papers), Additive Manufacturing and 3D Printing Technologies (2 papers), Antibiotic Use and Resistance (2 papers), Biomedical Ethics and Regulation (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Economics and Econometrics (265 citations), Applied Microbiology and Biotechnology (15 citations), Dermatology (57 citations), Statistics and Probability (53 citations) and Physiology (145 citations). Shane Garner has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Harry Ischiropoulos, Michael Francis Beers, Stephen R. Thom, S. Tsuyoshi Ohnishi, D. L. Fisher, Jelle Tichelaar, Nemesha Desai, Anthony David Ormerod, HV Hogerzeil and Ser‐Ling Chua. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Value in Health, European Journal of Clinical Pharmacology, Journal of Clinical Investigation and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.